Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279 · Completed

Last updated 2026-05-28

This clinical trial tested the effect of the medication liraglutide on weight management in adolescents who have gone through puberty and are living with obesity.

Status Completed The study has finished.

Phase Phase 3 Confirms effectiveness in a large group before approval.

Type Interventional (clinical trial)

Design Randomized, double-blind treatment study

Participants 251 people

Who can join Ages 12–17 · all sexes

Timeline Started 2016-09 · est. completion 2019-08

Where 33 sites · Belgium, Mexico, Russia, Sweden, United States

What this study is testing ClinicalTrials.gov NCT02918279 ↗

Description as written by the study sponsor.

This trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in pubertal adolescent subjects with obesity.

Treatments tested

Liraglutide Drug

Administered once daily subcutaneously (s.c., under the skin)
Placebo Drug

Administered once daily subcutaneously (s.c., under the skin)

Main thing measured	Change in BMI SDS (Week 0, Week 56)
Sponsor	Novo Nordisk A/S
Conditions studied	Metabolism and Nutrition Disorder, Obesity
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02918279 ↗